Clinical TrialsSearch results
Number of results: 2568
Completed
- Prospective study on safety of remote cardiac rehabilitation for patients after TAVI
- Patients undergoing TAVI due to severe aortic valve stenosis
- Ashikaga Kohei
- 2020-10-01
Recruiting
- Study on the effect of TM5614 on congenital FGF23-related hypophosphatemic rickets / osteomalacia
- FGF23-related hypophosphatemic rickets / osteomalacia
- ASOU Yoshinori
- 2022-03-28
Other
- Research study of QOL with leukotriene receptor antagonist ,pranlukast in asthmatic patients by use of Asthma Health Questionnaire-Japan QOL (AHQ-JAPAN QOL)
- Asthma
- Asthma QOL Research Study Group
- 2007-06-01
Not yet recruiting
- Multiple Dose Study to Evaluate Efficacy, Pharmacokinetics, Pharmacodynamics, Safety, and Tolerability of BMS-986322 in Participants with Moderate-to-Severe Psoriasis
- Moderate-to-Severe Psoriasis
- Attanasio Massimo
- 2023-06-25
Other
- Acute Decompensated Heart Failure Syndromes Registry in Japan Multicenter prospective observational cohort study
- Acute decompensated heart failure syndromes
- ATTEND registry committee
- 2007-06-12
Recruiting
- A study to examine the long-term safety, tolerability, and effectiveness of Pozelimab and Cemdisiran combination therapy in adult patients with Paroxysmal Nocturnal Hemoglobinuria
- Paroxysmal Nocturnal Hemoglobinuria
- Aurand Lisa
- 2023-04-09
Recruiting
- A C5 inhibitor-controlled Study to Evaluate the Efficacy and Safety of Pozelimab and Cemdisiran Combination Therapy in Adult Patients with Paroxysmal Nocturnal Hemoglobinuria (PNH) who are Complement Inhibitor Treatment-Naive or Have Not Recently Received Complement Inhibitor Therapy
- Paroxysmal Nocturnal Hemoglobinuria
- Aurand Lisa
- 2022-11-05
Other
- Efficacy and Safety of the Combination of Pozelimab and Cemdisiran Versus Continued Eculizumab or Ravulizumab Treatment in Adult Patients With Paroxysmal Nocturnal Hemoglobinuria
- Paroxysmal Nocturnal Hemoglobinuria
- Aurand Lisa
- 2024-04-02
Other
- Phase I study of SOF10 in patients with advanced solid tumors
- Solid Tumor
- Awaya Norihiro
- 2021-03-10
Other
- A PIVOTAL RANDOMIZED, OPEN-LABEL PHASE 3 STUDY OF HEADG2
- Histologically confirmed diagnosis of GBM according to WHO classification criteria
- Azuma Hisaya
- 2022-09-22